34 research outputs found
Electronic Structures of Amorphous Co-P and Ni-P Alloys by γ-ray Compton Scattering
γ-ray Compton scattering has been applied to study the electronic state of electro-deposited and melt-quenched amorphous Ni_P_ alloys, and electro-deposited amorphous Co_P_ alloy. Based on experimental Compton profiles, it is conclused that the charge transfer occurs from phosphorus atom to 3d band holes of transition metals, but 3d states may not be completely filled with electrons even in amorphous Ni_P_ alloy
Recommended from our members
THE PERFORMANCE TEST OF AN INITIAL iNET-LIKE RF NETWORK USING A HELICOPTER
Through the use of early iNET-prototype IP Transceiver technology, Kawasaki Heavy Industries, Ltd. (KHI) has been able to communicate with a flight test vehicle. This technology provides a two-way high-capacity communication that has not been achieved with conventional telemetry. KHI has been authorized to use S-band IP Transceivers since 2014 in Japan. Then various communication tests have been performed. Last year we presented the result of the performance test of initial iNET-like RF network using a tethered aerostat at ITC. As the next phase, we have a plan of the test using a helicopter. The test is going to be conducted in September. We will present the results at ITC. This paper describes plans of the test which includes improved data backfill techniques.International Foundation for TelemeteringProceedings from the International Telemetering Conference are made available by the International Foundation for Telemetering and the University of Arizona Libraries. Visit http://www.telemetry.org/index.php/contact-us if you have questions about items in this collection
Recommended from our members
PERFORMANCE TEST OF INITIAL iNET-LIKE RF NETWORK USING HELICOPTER (2018)
Kawasaki Heavy Industries, Ltd. (KHI) has been authorized to use S-band IP Transceivers since
2014 in Japan. We have been involved with tests for two-way high-capacity communication. We
presented the results of the performance test using a helicopter at ITC2016. We continued further
performance test in 2017-2018.International Foundation for TelemeteringProceedings from the International Telemetering Conference are made available by the International Foundation for Telemetering and the University of Arizona Libraries. Visit http://www.telemetry.org/index.php/contact-us if you have questions about items in this collection
Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardiovascular diseases including coronary artery disease and chronic heart failure (HF). However, their clinical implications in acute decompensated HF (ADHF) remain unclear. The aim of this study was to investigate the clinical roles of circulating PUFAs in patients with ADHF.Circulating levels of PUFAs, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (AA) and dihomo-gamma linoleic acid (DGLA), were measured on admission in 685 consecutive ADHF patients. Adverse events were defined as all-cause death and worsening HF.During a median follow-up period of 560 days, 262 (38.2%) patients had adverse events. Although patients with adverse events had lower n-6 PUFA (AA + DGLA) level than those without, n-3 PUFA (EPA + DHA) level was comparable between the groups. Kaplan-Meier analyses showed that lower n-6 PUFA level on admission was significantly associated with the composite of all-cause death and worsening HF, all-cause death, cardiovascular death and worsening HF (p < 0.001, p = 0.005, p = 0.021, p = 0.019, respectively). In a multivariate Cox model, lower n-6 PUFA level was independently associated with increased risk of adverse events (HR 0.996, 95% CI: 0.993-0.999, p = 0.027).Lower n-6 but not n-3 PUFA level on admission was significantly related to worse clinical outcomes in ADHF patients. Measurement of circulating n-6 PUFA levels on admission might provide information for identifying high risk ADHF patients